eMedicine Specialties > Radiology > Musculoskeletal

Hyperparathyroidism, Primary: Follow-up

Author: Bonnie Freitas, MD, Assistant Professor, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland
Coauthor(s): Alex Freitas, MD, Assistant Professor, UCLA Department of Radiology, Assistant Chief of Musculoskeletal Radiology, Renaissance Imaging Medical Associates
Contributor Information and Disclosures

Updated: Jan 24, 2008

Intervention

Ultrasonography-guided fine-needle aspiration and biopsy are infrequently performed in the setting of recurrent or persistent disease and equivocal imaging findings. The procedure may be used in conjunction with ethanol ablation as a therapeutic modality, but this is rarely indicated.

Medicolegal Pitfalls

Related Medscape topic:
Resource Center Medical Malpractice and Legal Issues

Special Concerns

  • Hyperparathyroidism in pregnancy is associated with increased perinatal morbidity and mortality rates related to hypocalcemic tetany in the newborn.30
  • Hyperparathyroidism is uncommon in women of childbearing age, but in patients who are affected, 15% are associated with neonatal tetany. The incidence of stillbirths and neonatal death is 2%.

Related Medscape topics:
Pediatrics/Neonatal Care Nursing

 


More on Hyperparathyroidism, Primary

Overview: Hyperparathyroidism, Primary
Imaging: Hyperparathyroidism, Primary
Follow-up: Hyperparathyroidism, Primary
Multimedia: Hyperparathyroidism, Primary
References
[ CLOSE WINDOW ]

References

  1. Albright F, Aub JC, Bauer W. Hyperparathyroidism, a common and polymorphic condition as illustrated by seventeen proved cases from one clinic. JAMA. 1934;102:1276-87.

  2. Albright F, Reifenstein EC Jr. Clinical hyperparathyroidism. In: Albright F, Reifenstein EC Jr, eds. The Parathyroid Glands and Metabolic Bone Disease: Selected Studies. Baltimore, Md: Williams & Wilkins; 1948:46-134.

  3. Mihai R, Wass JA, Sadler GP. Asymptomatic hyperparathyroidism--need for multicentre studies. Clin Endocrinol (Oxf). Feb 2008;68(2):155-64. [Medline].

  4. Silverberg SJ. Natural history of primary hyperparathyroidism. Endocrinol Metab Clin North Am. Sep 2000;29(3):451-64. [Medline].

  5. Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med. Dec 21 2000;343(25):1863-75. [Medline].

  6. Bringhurst FR, Demay MB, Kronenberg HM. Hormones and disorders of mineral metabolism. In: Williams RH, Foster DW, Kronenberg HM, Larsen PR, eds. Williams Textbook of Endocrinology. 9th ed. Orlando, Fla: Harcourt Brace & Co; 1998:1172-80.

  7. Lenchik L, Sartoris DJ. Orthopedic aspects of metabolic bone disease. Orthop Clin North Am. Jan 1998;29(1):103-34. [Medline].

  8. Cotran RS, Kumar V, Robbins SL. Robbins Pathologic Basis of Disease. 5th ed. Philadelphia, Pa: WB Saunders Co; 1994:1144-6.

  9. Mankin HJ. Metabolic bone disease. J Bone Joint Surg. 1994;76-A:760-88. [Full Text].

  10. Hayes CW, Conway WF. Hyperparathyroidism. Radiol Clin North Am. Jan 1991;29(1):85-96. [Medline].

  11. Resnick D, Niwayama G. Parathyroid disorders and renal osteodystrophy. In: Resnick D, Niwayama G, eds. Diagnosis of Bone and Joint Disorders. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1988:2219-49.

  12. Genant HK. Quantitative bone mineral analysis. In: Resnick D, Niwayama G, eds. Diagnosis of Bone and Joint Disorders. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1988:2006-17.

  13. Gleason DC, Potchen EJ. The diagnosis of hyperparathyroidism. Radiol Clin North Am. Aug 1967;5(2):277-87. [Medline].

  14. Inoue Y, Kaji H, Hisa I, et al. Vitamin D status affects osteopenia in postmenopausal patients with primary hyperparathyroidism. Endocr J. Jan 10 2008;epub ahead of print. [Medline]. [Full Text].

  15. Moosgaard B, Christensen SE, Vestergaard P, et al. Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clin Endocrinol (Oxf). Jan 8 2008;epub ahead of print. [Medline].

  16. Fogelman I, Cook GJ. Scintigraphy in metabolic bone disease. In: Favus MJ, Goldring SR, Christakos S, eds. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 4th ed. Hagerstown, Md: Lippincott Williams & Wilkins; 1999:150-2.

  17. Jergas MD, Genant HK. Radiology of osteoporosis. In: Favus MJ, Goldring SR, Christakos S, eds. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 4th ed. Hagerstown, Md: Lippincott Williams & Wilkins; 1999:160-5.

  18. Mayo-Smith W, Rosenthal DI. Radiographic appearance of osteopenia. Radiol Clin North Am. Jan 1991;29(1):37-47. [Medline].

  19. Reynolds WA, Karo JJ. Radiologic diagnosis of metabolic bone disease. Orthop Clin North Am. Nov 1972;3(3):521-43. [Medline].

  20. Pugh DG. Subperiosteal resorption of bone; a roentgenologic manifestation of primary hyperparathyroidism and renal osteodystrophy. Am J Roentgenol Radium Ther Nucl Med. Oct 1951;66(4):577-86. [Medline].

  21. Rodgers SE, Lew JI, Solórzano CC. Primary hyperparathyroidism. Curr Opin Oncol. Jan 2008;20(1):52-8. [Medline].

  22. Erbil Y, Kapran Y, Issever H, et al. The positive effect of adenoma weight and oxyphil cell content on preoperative localization with 99mTc-sestamibi scanning for primary hyperparathyroidism. Am J Surg. Jan 2008;195(1):34-9. [Medline].

  23. Gupta Y, Ahmed R, Happerfield L, et al. P-glycoprotein expression is associated with sestamibi washout in primary hyperparathyroidism. Br J Surg. Dec 2007;94(12):1491-5. [Medline].

  24. Carlier T, Oudoux A, Mirallié E, et al. (99m)Tc-MIBI pinhole SPECT in primary hyperparathyroidism: comparison with conventional SPECT, planar scintigraphy and ultrasonography. Eur J Nucl Med Mol Imaging. Oct 25 2007;epub ahead of print. [Medline].

  25. Siegel A, Mancuso M, Seltzer M. The spectrum of positive scan patterns in parathyroid scintigraphy. Clin Nucl Med. Oct 2007;32(10):770-4. [Medline].

  26. Prasannan S, Davies G, Bochner M, Kollias J, Malycha P. Minimally invasive parathyroidectomy using surgeon-performed ultrasound and sestamibi. ANZ J Surg. Sep 2007;77(9):774-7. [Medline].

  27. Gotway MB, Reddy GP, Webb WR, et al. Comparison between MR imaging and 99mTc MIBI scintigraphy in the evaluation of recurrent of persistent hyperparathyroidism. Radiology. Mar 2001;218(3):783-90. [Medline]. [Full Text].

  28. Gritzmann N, Koischwitz D, Rettenbacher T. Sonography of the thyroid and parathyroid glands. Radiol Clin North Am. Sep 2000;38(5):1131-45, xii. [Medline].

  29. Weber AL, Randolph G, Aksoy FG. The thyroid and parathyroid glands. CT and MR imaging and correlation with pathology and clinical findings. Radiol Clin North Am. Sep 2000;38(5):1105-29. [Medline].

  30. Gabbe SG, Neibyl JR, Simpson JL, eds. Obstetrics: Normal and Problem Pregnancies. 3rd ed. London, England: Churchill Livingstone; 1996:1065-8.

  31. Eigelberger MS, Clark OH. Surgical approaches to primary hyperparathyroidism. Endocrinol Metab Clin North Am. Sep 2000;29(3):479-502. [Medline].

  32. Townsend CM Jr, Beauchamp RD, Evers BM, Mattox KL, eds. Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 16th ed. Philadelphia, Pa: WB Saunders Co; 2001:632-7.

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

von Recklinghausen's disease of bone, von Recklinghausen disease of bone, generalized osteitis fibrosa cystica, PTH, parathyroid glands, multiple endocrine neoplasia syndrome type 1, MEN 1 / MEN-1, brown tumor

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Bonnie Freitas, MD, Assistant Professor, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland
Bonnie Freitas, MD is a member of the following medical societies: Alpha Omega Alpha and American College of Physicians-American Society of Internal Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Alex Freitas, MD, Assistant Professor, UCLA Department of Radiology, Assistant Chief of Musculoskeletal Radiology, Renaissance Imaging Medical Associates
Alex Freitas, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Radiology, Radiological Society of North America, and Society of Skeletal Radiology
Disclosure: Nothing to disclose.

Medical Editor

Leon Lenchik, MD, Director, Densitometry Minifellowship, Assistant Professor, Department of Radiology, Wake Forest University Medical Center
Leon Lenchik, MD is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, and Radiological Society of North America
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

Managing Editor

Wilfred CG Peh, MD, MBBS, FRCP(Glasg), FRCP(Edin), FRCR, MHSM, Clinical Professor, Faculty of Medicine, National University of Singapore; Senior Consultant Radiologist, Programme Office, Singapore Health Services
Wilfred CG Peh, MD, MBBS, FRCP(Glasg), FRCP(Edin), FRCR, MHSM is a member of the following medical societies: American Roentgen Ray Society, British Institute of Radiology, International Skeletal Society, Radiological Society of North America, Royal College of Physicians, and Royal College of Radiologists
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

Felix S Chew, MD, MBA, EdM, Professor, Department of Radiology, Vice Chairman for Radiology Informatics, Section Head of Musculoskeletal Radiology, University of Washington
Felix S Chew, MD, MBA, EdM is a member of the following medical societies: American Roentgen Ray Society, Association of University Radiologists, and Radiological Society of North America
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.